Retifanlimab-dlwr (Intravenous)

Active Ingredients

retifanlimab-dlwr

Drug Classes

Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Scoring is done by our AI based assistant on the data from the FDA and other sources

6.1

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

Retifanlimab-dlwr (Intravenous): Alternative Drugs By Action

7.8

Opdivo

7.8

Pembrolizumab

7.4

Zynyz

7.4

Dostarlimab

7.4

Jemperli

7.4

Retifanlimab

7.4

Cemiplimab

7.4

Keytruda

6.9

Loqtorzi

6.7

Cemiplimab-rwlc (Intravenous)

6.5

Atezolizumab

6.5

Imfinzi

6.1

Durvalumab

6.1

Retifanlimab-dlwr (Intravenous)

5.5

Avelumab

5.5

Toripalimab-tpzi (Intravenous)

5.2

Libtayo

5.0

Nivolumab

4.8

Tecentriq

4.8

Toripalimab